Treatment of tardive dyskinesia.
D014150:Antipsychotic Agents / Q000009:adverse effects; D004298:Dopamine / Q000378:metabolism; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D006801:Humans; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D014150:Antipsychotic Agents; D005680:gamma-Aminobutyric Acid; D004298:Dopamine